tiprankstipranks
Vyant Bio (DE:1C8)
FRANKFURT:1C8

Vyant Bio (1C8) Financial Statements

0 Followers

Vyant Bio Financial Overview

Vyant Bio's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Vyant Bio is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 165.00K$ 303.00K$ -2.53M$ 1.51M$ 1.95M
Gross Profit$ -139.00K$ -83.00K$ -1.10M$ 78.00K$ 575.00K
EBIT$ -4.34M$ -4.40M$ -2.63M$ -4.47M$ -4.19M
EBITDA$ -4.13M$ -4.16M$ -2.63M$ -3.94M$ -3.73M
Net Income Common Stockholders$ -5.80M$ -9.16M$ -24.85M$ -4.46M$ -4.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.70M$ 16.44M$ 20.61M$ 23.20M$ 26.48M
Total Assets$ 26.81M$ 32.53M$ 37.64M$ 61.22M$ 65.40M
Total Debt$ 2.19M$ 2.25M$ 1.20M$ 1.00M$ 1.22M
Net Debt$ -9.51M$ -14.19M$ -19.41M$ -22.20M$ -25.27M
Total Liabilities$ 10.02M$ 10.16M$ 6.35M$ 5.30M$ 5.34M
Stockholders Equity$ 16.79M$ 22.37M$ 31.29M$ 55.92M$ 60.06M
Cash Flow-
Free Cash Flow$ -4.49M$ -4.00M$ -3.02M$ -3.32M$ -6.58M
Operating Cash Flow$ -4.16M$ -3.97M$ -3.00M$ -3.32M$ -6.08M
Investing Cash Flow$ -373.00K$ -60.00K$ -73.00K$ 49.00K$ -494.00K
Financing Cash Flow$ -202.00K$ -136.00K$ 481.00K$ -11.00K$ -10.00K
Currency in USD

Vyant Bio Earnings and Revenue History

Vyant Bio Debt to Assets

Vyant Bio Cash Flow

Vyant Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis